Xylem (NYSE:XYL) Stock Price Expected to Rise, Citigroup Analyst Says

Xylem (NYSE:XYL) had its target price raised by analysts at Citigroup from $173.00 to $182.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the industrial products company’s stock. Citigroup’s price objective indicates a potential upside of 20.12% from the stock’s current price.

Several other equities analysts have also issued reports on the company. Stifel Nicolaus lifted their price target on Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. UBS Group upped their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a research note on Tuesday, August 5th. TD Cowen raised their price target on shares of Xylem from $125.00 to $130.00 and gave the company a “hold” rating in a research report on Tuesday, August 26th. Finally, Argus set a $170.00 price objective on shares of Xylem in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $166.20.

Xylem Stock Performance

Shares of XYL opened at $151.52 on Wednesday. Xylem has a one year low of $100.47 and a one year high of $154.27. The company has a 50-day simple moving average of $144.59 and a two-hundred day simple moving average of $133.92. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.43. The firm has a market capitalization of $36.89 billion, a PE ratio of 38.95, a price-to-earnings-growth ratio of 2.50 and a beta of 1.13.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. During the same quarter last year, the business posted $1.11 EPS. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, analysts anticipate that Xylem will post 4.65 EPS for the current fiscal year.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in XYL. Vanguard Group Inc. boosted its stake in Xylem by 2.4% during the second quarter. Vanguard Group Inc. now owns 29,697,829 shares of the industrial products company’s stock valued at $3,841,711,000 after buying an additional 691,285 shares during the last quarter. Geode Capital Management LLC increased its position in Xylem by 2.3% in the second quarter. Geode Capital Management LLC now owns 6,141,231 shares of the industrial products company’s stock worth $791,029,000 after purchasing an additional 136,605 shares during the last quarter. Amundi raised its stake in Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after purchasing an additional 830,337 shares in the last quarter. Impax Asset Management Group plc lifted its position in Xylem by 13.7% during the second quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock valued at $709,183,000 after purchasing an additional 663,191 shares during the last quarter. Finally, Swedbank AB grew its stake in shares of Xylem by 19.0% in the 3rd quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after buying an additional 830,821 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.